Gaudium IVF and Women Health: The Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended September…
Gaudium IVF and Women Health (GAUDIUMIVF) filed a disclosure titled "The Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2026". The company is valued at about ₹783 crore.
What happened
Gaudium IVF and Women Health (GAUDIUMIVF) filed a disclosure with the exchanges on 12 November 2026 at 08:36 PM titled "The Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2026".
From the filing: "Gaudium IVF and Women Health Limited has submitted to the Exchange, the Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2026"
Company snapshot
Gaudium IVF and Women Health is a micro-cap company, with a market value of about ₹783 crore.
The stock last traded at ₹107.6, against a 52-week range of ₹69.18–₹163.2 (34.1% below the high).
Before this filing the shares had moved +4.2% over the month and −12.3% over three months. Average daily turnover over the last 20 sessions was about ₹3.46 crore.
Promoters held 71.29% at the end of Q1 FY27. Foreign institutions owned 3.02% and domestic institutions 2.22%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q3 FY26 | 25 | 3.6 | 0.59 |
| Q4 FY26 | 30 | 8.4 | 1.34 |
| Q1 FY27 | 19 | 1.8 | 0.25 |
What history shows
BCEIE's records show 4 previous results filings from the company since May 2026.
After those filings, the stock fell 2.9% on average the next trading day and was down 10.4% on average after five days (4 filings with price data).
Market-wide, 11,743 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 13 Aug 2026 | A press release dated August 13, 2026, titled "press release on… | −4.0% | −11.4% |
| 13 Aug 2026 | , the Unaudited Standalone and Consolidated Financial Results for… | −4.0% | −11.4% |
| 28 May 2026 | Standalone And Consolidated Audited Financial Results For The… | −1.8% | −9.4% |
| 28 May 2026 | , the financial results for the quarter and year ended March 31, 2026. | −1.8% | −9.4% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 12 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.